| Stage | MTUS | % of rev | NUE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $337M | 100.00% | $10.4B | 100.00% | NUE ×30.83 |
| Gross profit | $36M | 10.77% | $2.0B | 19.56% | NUE +8.8pp |
| Operating income | $12M | 3.65% | $1.6B | 15.67% | NUE +12.0pp |
| Pre-tax income | $32M | 9.58% | $1.6B | 15.63% | NUE +6.1pp |
| Net income | $24M | 7.06% | $1.3B | 12.31% | NUE +5.3pp |
| Stage | MTUS | NUE | Gap · A − B |
|---|---|---|---|
| Revenue | $337M100.00% | $10.4B100.00% | NUE ×30.83 |
| Gross profit | 10.77%$36M | 19.56%$2.0B | NUE +8.8pp |
| Operating income | 3.65%$12M | 15.67%$1.6B | NUE +12.0pp |
| Pre-tax income | 9.58%$32M | 15.63%$1.6B | NUE +6.1pp |
| Net income |
| 7.06%$24M |
| 12.31%$1.3B |
| NUE +5.3pp |
None
No disclosed counterparties: MTUS.